Holen Sie sich die Stockscreener-App
16.40
1.11%
0.18
Rallybio Corp Aktie (RLYB) Neueste Nachrichten
Form 4 Rallybio Corp: Helen M. Boudreau (Director) For: 16 October - Investing.com Canada
Rallybio Corp SEC Filing (Oct 16, 2026) - Stock Titan
Form 4 Rallybio Corp: Robert Lorne Hopfner (Director) For: 12 October - Investing.com India
Form 4 Rallybio Corp: Robert Lorne Hopfner (Director) For: 12 October - Investing.com Nigeria
Form 4 Rallybio Corp: Robert Lorne Hopfner (Director) For: 12 October - Investing.com UK
A $215M financing would split ownership three ways in Rallybio (Nasdaq: RLYB)'s proposed Avenzo merger. - Stock Titan
Form 4 Rallybio Corp: Jonathan I. Lieber (CFO) For: 9 October - Investing.com Nigeria
Form 4 Rallybio Corp For: 9 October By Investing.com - Investing.com South Africa
Form 4 Rallybio Corp For: 9 October By Investing.com - Investing.com Nigeria
Form 4 Rallybio Corp For: 9 October By Investing.com - Investing.com UK
Form 4 Rallybio Corp For: 2 October By Investing.com - Investing.com Nigeria
Form 4 Rallybio Corp For: 2 October By Investing.com - Investing.com South Africa
The proposed Avenzo merger would pair $215M financing with an ownership split for Rallybio (RLYB) holders. - Stock Titan
Form 4 Rallybio Corp For: 28 September By Investing.com - Investing.com South Africa
Form 4 Rallybio Corp For: 28 September - Investing.com India
Form 4 Rallybio Corp For: 28 September By Investing.com - Investing.com Australia
Form 4 Rallybio Corp For: 28 September By Investing.com - Investing.com Nigeria
Form 4 Rallybio Corp For: 28 September By Investing.com - Investing.com UK
Rallybio (NASDAQ: RLYB) holders expected to own 2.8% of new Avenzo - Stock Titan
Rallybio (NASDAQ: RLYB) Announces CFO Jonathan Lieber's Shift to Part-Time Role Starting September 15, 2026 - Kalkine Media
Rallybio's Jonathan Lieber to Shift to Part-Time CFO Role - TradingView
Rallybio Corp (RLYB) Debt 2025 - Stock Titan
Balyasny Asset Management L.P. Exits Rallybio Corp (RLYB) Stake in 13DG Filing - GuruFocus
Rallybio (RLYB) Holds Near $17 Ceiling as Traders Weigh Breakout PotentialWave Extension - vinanet.vn
Rallybio Company Profile & Introduction - Moomoo
Rallybio (NASDAQ:RLYB) Upgraded at Wall Street Zen - MarketBeat
Rallybio Corporation (RLYB) holders report 3.56% stake in Schedule 13G/A - Stock Titan
Cormorant Asset Management (RLYB) now reports 0% beneficial ownership of Rallybio - Stock Titan
RLYB Q1 2026 Earnings: Wider-than-Expected Loss Underscores Cost of Advancing Rare-Disease PipelineEBITDA Estimate Trend - vinanet.vn
Rallybio Corporation (NASDAQ:RLYB) Sees Large Drop in Short Interest - MarketBeat
Rallybio Corp (RLYB) sees Balyasny group report 0% ownership in 13G/A - Stock Titan
Rallybio Corp (NASDAQ: RLYB) Stock Price, News & Analysis - Kalkine
RLYB Q1 2026 Earnings: Wider Loss Highlights Acceleration of Clinical-Spend Run-RateGuidance vs Actual - vinanet.vn
Rallybio Corp (RLYB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rallybio (NASDAQ:RLYB) Releases Earnings Results, Beats Estimates By $8.81 EPS - MarketBeat
Rallybio Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
FMR LLC reports 15% Rallybio Corp (RLYB) stake, including 5% fund holding - Stock Titan
Rallybio Corp 2Q 2026: Revenue $0 Net income $43.67M, EPS $7.53— 10-Q Summary - TradingView
Laurion Capital exits Rallybio (RLYB) position, reports 0% beneficial ownership - Stock Titan
Rallybio Q1 2026 Earnings: Wider-than-Expected Loss as Development Costs PersistGeographic Revenue Trends - dars.gov.et
Rallybio Q1 2026 Earnings: Wider-than-Expected Loss as Development Costs PersistRevenue Miss Report - vinanet.vn
RLYB|Rallybio Corp|Price:16.350|Chg%:+0.160 - TradingKey
Rallybio Corp (RLYB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rallybio Corp (RLYB) Balance Sheet - TradingKey
Rallybio Corp (RLYB) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Rallybio Corp (RLYB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rallybio Corp (RLYB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Rallybio Corporation (NASDAQ:RLYB) Sees Significant Decline in Short Interest - MarketBeat
RLYB|Rallybio Corp|Price:16.160|Chg%:-0.150 - TradingKey
Rallybio Market Sentiment - Benzinga España
0.68%
3.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):